Rhenium offers a comprehensive genetic portfolio that includes a range of advanced solutions for genetic analysis. Our portfolio encompasses Sanger sequencing, fragment analysis, digital PCR (dPCR), and quantitative PCR (qPCR) technologies. These cutting-edge tools enable reliable insights throughout various applications, including gene therapy product development, clinical research and diagnostics, and forensic workflows.
Our team of genetic analysis experts is dedicated to guiding our customers through the complexities of genetic analysis. We provide application and technical support to ensure that our customers can effectively utilize our genetic analysis solutions and derive meaningful results.

Showing 1–12 of 16 results